Author

Mutita Surakijboworn

Institutions: Chulalongkorn University, King Chulalongkorn Memorial Hospital

Observed institutions: Chulalongkorn University, King Chulalongkorn Memorial Hospital

OpenAlex ID: A5115022946

Aggressive systemic mastocytosis presenting as cryptogenic cirrhosis, refractory ascites, and cytopenias

2026 · Tatsanai Sattayaraksa, Suwannaporn Yaophrukchai, et al. · Journal of Hematology and Transfusion Medicine (วารสารโลหิตวิทยาและเวชศาสตร์บริการโลหิต)

PDF

Feasibility and outcomes of decentralized point-of-care CD19 CAR T cell for relapsed large B cell lymphoma in resource-limited settings

2026 · Koramit Suppipat, Supannikar Tawinwung, et al. · Molecular Therapy Oncology

Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial

2025 · Mutita Surakijboworn, Chantana Polprasert, et al. · Scientific Reports

PDF

The Effectiveness of Levofloxacin in Prevention of Febrile Episodes in Non-Hodgkin Lymphoma Patients Receiving Rituximab, Cyclophosphamide, Vincristine, Doxorubicin and Prednisolone (R-CHOP)

2024 · Mutita Surakijboworn, Noppachan Uaprasert, et al. · Blood

PDF

Works count: 4

Citation count:

H-index:

I10-index: